Site icon Fact.MR Blog

Growing Prevalence of Chronic Obstructive Pulmonary Disease (COPD) to Drive Demand for Smoking Cessation Products

Nicotine de-addiction product sales are likely to grow at a steady pace, as quit smoking and smoking cessation gain momentum. E-cigarettes are increasingly losing favor, owing to lack of empirical support from researchers on their effectiveness. Vaping, on the other hand, is gaining popularity, even though it is yet to be officially categorized as a nicotine de-addiction or smoking cessation technique. These insights are according to a new research by Fact.MR, which tracks historical data and future projections. A summary of the report is available upon request.

Although smokers are unanimous in acknowledging the risk they put themselves and those around them, the awareness has not translated into quitting smoking altogether. Although smoking is becoming less popular in a number of countries, the total number of smokers is still over a billion – or roughly 1 in 6 people. Smoking continues to be a major healthcare concern, not only for smokers, but also for those inhale the smoke.

REQUEST FOR SAMPLE

Stringent Smoke-free Air Laws Triggering Smoking Cessation Products Market Growth

The market is expected to show positive growth rate due to smoke-free air laws which are aimed at restricting exposure of minors to smoking products and protect consumers from second-hand smoking. These laws are imposed by various organizations and governments of particular countries. For instance, United States banned smoking in most public places under the Department of Health Functions Clarification Amendment Act of 2006.

Thus, growth prospects of cessation products market are attributed to these smoke-free air laws which limit promoting and advertising of tobacco products and exhort smoker population to quit smoking using smoking cessation products. Thus, the market is expected to witness 1.7X more demand in coming years.

Growing COPD Diseases Driving Demand

Tobacco smoking is the primary cause of Chronic Obstructive Pulmonary Disease (COPD). According to World Health Organization (WHO), more than 260 million patients across the world are suffering from Chronic Obstructive Pulmonary Disease and it is likely to become third leading cause of death by the end of 2030.

As there is no cure for this life-threatening disease, demand for smoking cessation products is rising at a rapid pace. Thus, consumer awareness is leading to market growth by approximately 23%.

Manufacturers in smoking cessation products market are offering personalized smoking cessation products to help patients with COPD management, thus improving sales of smoking cessation products in coming years.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Exit mobile version